Cargando…
Association of elevated inflammatory markers and severe COVID-19: A meta-analysis
Our study aimed to assess the existing evidence on whether severe coronavirus disease 2019 (COVID-19) is associated with elevated inflammatory markers. The PubMed, Embase, Web of Science, Scopus, Chinese National Knowledge Infrastructure, WanFang, and China Science and Technology Journal databases w...
Autores principales: | Ji, Pan, Zhu, Jieyun, Zhong, Zhimei, Li, Hongyuan, Pang, Jielong, Li, Bocheng, Zhang, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676531/ https://www.ncbi.nlm.nih.gov/pubmed/33217868 http://dx.doi.org/10.1097/MD.0000000000023315 |
Ejemplares similares
-
Clinical characteristics of 2,459 severe or critically ill COVID-19 patients: A meta-analysis
por: Zhong, Zhimei, et al.
Publicado: (2021) -
Risk factors of severe cases with COVID-19: a meta-analysis
por: Ou, Mingchun, et al.
Publicado: (2020) -
Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis
por: Zhu, Jieyun, et al.
Publicado: (2020) -
Efficacy and safety of baricitinib in patients with severe COVID-19: A systematic review and meta-analysis
por: Song, Wenxin, et al.
Publicado: (2023) -
The Expanding Burden of Elevated Blood Pressure in China: Evidence From Jiangxi Province, 2007–2010
por: Xu, Gang, et al.
Publicado: (2015)